Cargando…
High loading-dose of dupilumab resulted in rapid disease control in pediatric patients with atopic dermatitis
BACKGROUND: The real-world experience of dupilumab in Chinese is limited, and the initial loading dose has not yet been deeply explored in patients aged <6 years. OBJECTIVE: To explore the efficacy and safety of dupilumab in Chinese patients with moderate-to-severe atopic dermatitis and investiga...
Autores principales: | Wang, Ao, Zhou, Yuan, Luo, Yang, Gao, Yingxia, Chen, Jingsi, Li, Wei, Luo, Xiaoyan, Yao, Xu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157040/ https://www.ncbi.nlm.nih.gov/pubmed/37153599 http://dx.doi.org/10.3389/fimmu.2023.1160710 |
Ejemplares similares
-
Dupilumab for atopic dermatitis
Publicado: (2019) -
The Posology of Dupilumab in Pediatric Patients With Atopic Dermatitis
por: Kamal, Mohamed A., et al.
Publicado: (2021) -
Integrated metabolomics and lipidomics study of patients with atopic dermatitis in response to dupilumab
por: Zhang, Lishan, et al.
Publicado: (2022) -
Severe atopic dermatitis and dupilumab
por: Bernardo, Wanderley, et al.
Publicado: (2023) -
Is Dupilumab as Effective in Intrinsic Atopic Dermatitis as It Is in Extrinsic Atopic Dermatitis?
por: Gelato, Federica, et al.
Publicado: (2023)